Development of novel darunavir amorphous solid dispersions with mesoporous carriers

被引:13
作者
Zolotov, Sergey A. [1 ]
Demina, Natalia B. [2 ]
Zolotova, Anna S. [1 ]
Shevlyagina, Natalia V. [3 ]
Buzanov, Grigorii A. [4 ]
Retivov, Vasilii M. [5 ]
Kozhukhova, Evgeniia I. [5 ]
Zakhoda, Oleg Y. [1 ]
Dain, Igor A. [1 ]
Filatov, Andrei R. [1 ]
Cheremisin, Alexander M. [1 ]
机构
[1] Amedart LLC, Moscow, Russia
[2] Sechenov First Moscow State Med Univ, Inst Pharm, Dept Pharmaceut Technol, Moscow, Russia
[3] Gamaleya Fed Res Ctr Epidemiol & Microbiol, Moscow, Russia
[4] NRC Kurchatov Inst, Inst Chem Reagents & High Purity Chem Subst, Moscow, Russia
[5] Russian Acad Sci, Karnakov Inst Gen & Inorgan Chem, Moscow, Russia
关键词
Amorphous solid dispersion; Differential scanning calorimetry; Dissolution testing; X-ray powder diffraction; Darunavir; Mesoporous silica; Magnesium aluminum silicate;
D O I
10.1016/j.ejps.2021.105700
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this work was to compare mesopomus carriers based on silica and magnesium aluminosilicate in the amorphous solid dispersion production. Darunavir has been selected as an active pharmaceutical ingredient that is classified as a Class 2 BCS substance and exists in two commercially available forms: crystalline ethanolate and amorphous. In the course of the study, the conditions for the preparation of amorphous samples with the selected carriers were evaluated within the framework of the most common methods for obtaining solid dispersions - hot-melt extrusion, solvent wetting, and spray drying. It was determined that the obtained dispersion properties almost completely repeat the properties of the corresponding carriers. The resulting dispersions were examined in a dissolution test and the best ones was used to formulate tablets, which were studied in an in vitro dissolution test with the original Prezista. The proposed tablet formulation showed improved dissolution compared to the original one. It was also found that silica supports have a greater positive contribution to darunavir dissolution - both ethanolate or amorphous forms.
引用
收藏
页数:13
相关论文
共 50 条
[21]   Downstream processing of amorphous solid dispersions into orodispersible tablets [J].
Kokott, Marcel ;
Klinken, Stefan ;
Breitkreutz, Jorg ;
Wiedey, Raphael .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 631
[22]   Myricetin Amorphous Solid Dispersions-Antineurodegenerative Potential [J].
Rosiak, Natalia ;
Tykarska, Ewa ;
Cielecka-Piontek, Judyta .
MOLECULES, 2024, 29 (06)
[23]   Novel cellulose-based amorphous solid dispersions enhance quercetin solution concentrations in vitro [J].
Gilley, Andrew D. ;
Arca, Hale Cigdem ;
Nichols, Brittany L. B. ;
Mosquera-Giraldo, Laura I. ;
Taylor, Lynne S. ;
Edgar, Kevin J. ;
Neilson, Andrew P. .
CARBOHYDRATE POLYMERS, 2017, 157 :86-93
[24]   Stabilizing Mechanisms of β-Lactoglobulin in Amorphous Solid Dispersions of Indomethacin [J].
Kabedev, Aleksei ;
Zhuo, Xuezhi ;
Leng, Donglei ;
Fodera, Vito ;
Zhao, Min ;
Larsson, Per ;
Bergstrom, Christel A. S. ;
Lobmann, Korbinian .
MOLECULAR PHARMACEUTICS, 2022, 19 (11) :3922-3933
[25]   Manufacturing strategies to develop amorphous solid dispersions: An overview [J].
Mendonsa, Nicole ;
Almutairy, Bjad ;
Kallakunta, Venkata Raman ;
Sarabu, Sandeep ;
Thipsay, Priyanka ;
Bandari, Suresh ;
Repka, Michael A. .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 55
[26]   Delivery of Poorly Soluble Compounds by Amorphous Solid Dispersions [J].
Lee, Thomas W. Y. ;
Boersen, Nathan A. ;
Hui, H. W. ;
Chow, S. F. ;
Wan, K. Y. ;
Chow, Albert H. L. .
CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (03) :303-324
[27]   Orodispersible films based on amorphous solid dispersions of tetrabenazine [J].
Senta-Loys, Zoe ;
Bourgeois, Sandrine ;
Valour, Jean-Pierre ;
Briancon, Stephanie ;
Fessi, Hatem .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 518 (1-2) :242-252
[28]   Solubility advantage from amorphous etoricoxib solid dispersions [J].
Dani, Prateek ;
Puri, Vibha ;
Bansal, A. K. .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2014, 40 (01) :92-101
[29]   Effect of Polymer Hygroscopicity on the Phase Behavior of Amorphous Solid Dispersions in the Presence of Moisture [J].
Rumondor, Alfred C. F. ;
Taylor, Lynne S. .
MOLECULAR PHARMACEUTICS, 2010, 7 (02) :477-490
[30]   Development of Orodispersible Tablets with Solid Dispersions of Fenofibrate and Co-Processed Mesoporous Silica for Improved Dissolution [J].
Baumgartner, Ana ;
Planinsek, Odon .
PHARMACEUTICS, 2024, 16 (08)